Immune cells: potential carriers or agents for drug delivery to the central nervous system

Drug delivery systems (DDS) have recently emerged as a promising approach for the unique advantages of drug protection and targeted delivery. However, the access of nanoparticles/drugs to the central nervous system (CNS) remains a challenge mainly due to the obstruction from brain barriers. Immune c...

Full description

Saved in:
Bibliographic Details
Published in:Military medical research 2024-03, Vol.11 (1), p.19-19, Article 19
Main Authors: Zhang, Shan-Shan, Li, Ruo-Qi, Chen, Zhong, Wang, Xiao-Ying, Dumont, Aaron S, Fan, Xiang
Format: Article
Language:English
Subjects:
Antigens
Blood vessels
Blood-Brain Barrier
Brain
Cell adhesion & migration
Central nervous system
Central Nervous System Diseases - drug therapy
Chemokines
Drug Delivery Systems
Drugs
Epilepsy
Fatty acids
Glycoproteins
Homeostasis
Humans
Immune cells
Leukocytes
Ligands
Medical research
Multiple sclerosis
Nanoparticles
Nanoparticles - therapeutic use
Nervous system
Physiology
Spinal cord
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c459t-453665047a503e871afb6b23b8b288f70e8feba21abb5f3e754e3e8a9f7751873
container_end_page 19
container_issue 1
container_start_page 19
container_title Military medical research
container_volume 11
creator Zhang, Shan-Shan
Li, Ruo-Qi
Chen, Zhong
Wang, Xiao-Ying
Dumont, Aaron S
Fan, Xiang
description Drug delivery systems (DDS) have recently emerged as a promising approach for the unique advantages of drug protection and targeted delivery. However, the access of nanoparticles/drugs to the central nervous system (CNS) remains a challenge mainly due to the obstruction from brain barriers. Immune cells infiltrating the CNS in the pathological state have inspired the development of strategies for CNS foundation drug delivery. Herein, we outline the three major brain barriers in the CNS and the mechanisms by which immune cells migrate across the blood-brain barrier. We subsequently review biomimetic strategies utilizing immune cell-based nanoparticles for the delivery of nanoparticles/drugs to the CNS, as well as recent progress in rationally engineering immune cell-based DDS for CNS diseases. Finally, we discuss the challenges and opportunities of immune cell-based DDS in CNS diseases to promote their clinical development.
doi_str_mv 10.1186/s40779-024-00521-y
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e4dd5b88d2174408981517c661dabc94</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e4dd5b88d2174408981517c661dabc94</doaj_id><sourcerecordid>3037875236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-453665047a503e871afb6b23b8b288f70e8feba21abb5f3e754e3e8a9f7751873</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVJaUKaP9BDEeSSi1t9f-QWQtouBHppL70IyR5vvdjWRpID_vfV7qah9DTD8LwvM_Mi9IGST5Qa9TkLorVtCBMNIZLRZn2DLhiRorFc2bN_-nN0lfOOEEK5YNSyd-icGyksVfQC_dpM0zIDbmEc8y3exwJzGfyIW5_SACnjmLDf1mHGfW27tGxxB-PwDGnFJeLy-yCeS6qaGdJzXDLOay4wvUdvez9muHqpl-jnl4cf99-ax-9fN_d3j00rpC2NkFwpSYT2knAwmvo-qMB4MIEZ02sCpofgGfUhyJ6DlgIq522vtaRG80u0Ofl20e_cPg2TT6uLfnDHQUxb51MZ2hEciK6TwZiOUS0EMdZQSXWrFO18aK2oXjcnr32KTwvk4qYhH37jZ6iXOU4Yk0oLKSt6_R-6i0ua66WV4tpoybiqFDtRbYo5J-hfF6TEHYJ0pyBdDdIdg3RrFX18sV7CBN2r5G9s_A-LW5fv</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037875236</pqid></control><display><type>article</type><title>Immune cells: potential carriers or agents for drug delivery to the central nervous system</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Zhang, Shan-Shan ; Li, Ruo-Qi ; Chen, Zhong ; Wang, Xiao-Ying ; Dumont, Aaron S ; Fan, Xiang</creator><creatorcontrib>Zhang, Shan-Shan ; Li, Ruo-Qi ; Chen, Zhong ; Wang, Xiao-Ying ; Dumont, Aaron S ; Fan, Xiang</creatorcontrib><description>Drug delivery systems (DDS) have recently emerged as a promising approach for the unique advantages of drug protection and targeted delivery. However, the access of nanoparticles/drugs to the central nervous system (CNS) remains a challenge mainly due to the obstruction from brain barriers. Immune cells infiltrating the CNS in the pathological state have inspired the development of strategies for CNS foundation drug delivery. Herein, we outline the three major brain barriers in the CNS and the mechanisms by which immune cells migrate across the blood-brain barrier. We subsequently review biomimetic strategies utilizing immune cell-based nanoparticles for the delivery of nanoparticles/drugs to the CNS, as well as recent progress in rationally engineering immune cell-based DDS for CNS diseases. Finally, we discuss the challenges and opportunities of immune cell-based DDS in CNS diseases to promote their clinical development.</description><identifier>ISSN: 2054-9369</identifier><identifier>ISSN: 2095-7467</identifier><identifier>EISSN: 2054-9369</identifier><identifier>DOI: 10.1186/s40779-024-00521-y</identifier><identifier>PMID: 38549161</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Antigens ; Blood vessels ; Blood-Brain Barrier ; Brain ; Cell adhesion &amp; migration ; Central nervous system ; Central Nervous System Diseases - drug therapy ; Chemokines ; Drug Delivery Systems ; Drugs ; Epilepsy ; Fatty acids ; Glycoproteins ; Homeostasis ; Humans ; Immune cells ; Leukocytes ; Ligands ; Medical research ; Multiple sclerosis ; Nanoparticles ; Nanoparticles - therapeutic use ; Nervous system ; Physiology ; Spinal cord</subject><ispartof>Military medical research, 2024-03, Vol.11 (1), p.19-19, Article 19</ispartof><rights>2024. The Author(s).</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c459t-453665047a503e871afb6b23b8b288f70e8feba21abb5f3e754e3e8a9f7751873</cites><orcidid>0000-0001-7697-0378</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3037875236?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38549161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Shan-Shan</creatorcontrib><creatorcontrib>Li, Ruo-Qi</creatorcontrib><creatorcontrib>Chen, Zhong</creatorcontrib><creatorcontrib>Wang, Xiao-Ying</creatorcontrib><creatorcontrib>Dumont, Aaron S</creatorcontrib><creatorcontrib>Fan, Xiang</creatorcontrib><title>Immune cells: potential carriers or agents for drug delivery to the central nervous system</title><title>Military medical research</title><addtitle>Mil Med Res</addtitle><description>Drug delivery systems (DDS) have recently emerged as a promising approach for the unique advantages of drug protection and targeted delivery. However, the access of nanoparticles/drugs to the central nervous system (CNS) remains a challenge mainly due to the obstruction from brain barriers. Immune cells infiltrating the CNS in the pathological state have inspired the development of strategies for CNS foundation drug delivery. Herein, we outline the three major brain barriers in the CNS and the mechanisms by which immune cells migrate across the blood-brain barrier. We subsequently review biomimetic strategies utilizing immune cell-based nanoparticles for the delivery of nanoparticles/drugs to the CNS, as well as recent progress in rationally engineering immune cell-based DDS for CNS diseases. Finally, we discuss the challenges and opportunities of immune cell-based DDS in CNS diseases to promote their clinical development.</description><subject>Antigens</subject><subject>Blood vessels</subject><subject>Blood-Brain Barrier</subject><subject>Brain</subject><subject>Cell adhesion &amp; migration</subject><subject>Central nervous system</subject><subject>Central Nervous System Diseases - drug therapy</subject><subject>Chemokines</subject><subject>Drug Delivery Systems</subject><subject>Drugs</subject><subject>Epilepsy</subject><subject>Fatty acids</subject><subject>Glycoproteins</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Immune cells</subject><subject>Leukocytes</subject><subject>Ligands</subject><subject>Medical research</subject><subject>Multiple sclerosis</subject><subject>Nanoparticles</subject><subject>Nanoparticles - therapeutic use</subject><subject>Nervous system</subject><subject>Physiology</subject><subject>Spinal cord</subject><issn>2054-9369</issn><issn>2095-7467</issn><issn>2054-9369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1r3DAQhkVJaUKaP9BDEeSSi1t9f-QWQtouBHppL70IyR5vvdjWRpID_vfV7qah9DTD8LwvM_Mi9IGST5Qa9TkLorVtCBMNIZLRZn2DLhiRorFc2bN_-nN0lfOOEEK5YNSyd-icGyksVfQC_dpM0zIDbmEc8y3exwJzGfyIW5_SACnjmLDf1mHGfW27tGxxB-PwDGnFJeLy-yCeS6qaGdJzXDLOay4wvUdvez9muHqpl-jnl4cf99-ax-9fN_d3j00rpC2NkFwpSYT2knAwmvo-qMB4MIEZ02sCpofgGfUhyJ6DlgIq522vtaRG80u0Ofl20e_cPg2TT6uLfnDHQUxb51MZ2hEciK6TwZiOUS0EMdZQSXWrFO18aK2oXjcnr32KTwvk4qYhH37jZ6iXOU4Yk0oLKSt6_R-6i0ua66WV4tpoybiqFDtRbYo5J-hfF6TEHYJ0pyBdDdIdg3RrFX18sV7CBN2r5G9s_A-LW5fv</recordid><startdate>20240329</startdate><enddate>20240329</enddate><creator>Zhang, Shan-Shan</creator><creator>Li, Ruo-Qi</creator><creator>Chen, Zhong</creator><creator>Wang, Xiao-Ying</creator><creator>Dumont, Aaron S</creator><creator>Fan, Xiang</creator><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88F</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M1Q</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7697-0378</orcidid></search><sort><creationdate>20240329</creationdate><title>Immune cells: potential carriers or agents for drug delivery to the central nervous system</title><author>Zhang, Shan-Shan ; Li, Ruo-Qi ; Chen, Zhong ; Wang, Xiao-Ying ; Dumont, Aaron S ; Fan, Xiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-453665047a503e871afb6b23b8b288f70e8feba21abb5f3e754e3e8a9f7751873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antigens</topic><topic>Blood vessels</topic><topic>Blood-Brain Barrier</topic><topic>Brain</topic><topic>Cell adhesion &amp; migration</topic><topic>Central nervous system</topic><topic>Central Nervous System Diseases - drug therapy</topic><topic>Chemokines</topic><topic>Drug Delivery Systems</topic><topic>Drugs</topic><topic>Epilepsy</topic><topic>Fatty acids</topic><topic>Glycoproteins</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Immune cells</topic><topic>Leukocytes</topic><topic>Ligands</topic><topic>Medical research</topic><topic>Multiple sclerosis</topic><topic>Nanoparticles</topic><topic>Nanoparticles - therapeutic use</topic><topic>Nervous system</topic><topic>Physiology</topic><topic>Spinal cord</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Shan-Shan</creatorcontrib><creatorcontrib>Li, Ruo-Qi</creatorcontrib><creatorcontrib>Chen, Zhong</creatorcontrib><creatorcontrib>Wang, Xiao-Ying</creatorcontrib><creatorcontrib>Dumont, Aaron S</creatorcontrib><creatorcontrib>Fan, Xiang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Military Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Military Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Military medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Shan-Shan</au><au>Li, Ruo-Qi</au><au>Chen, Zhong</au><au>Wang, Xiao-Ying</au><au>Dumont, Aaron S</au><au>Fan, Xiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune cells: potential carriers or agents for drug delivery to the central nervous system</atitle><jtitle>Military medical research</jtitle><addtitle>Mil Med Res</addtitle><date>2024-03-29</date><risdate>2024</risdate><volume>11</volume><issue>1</issue><spage>19</spage><epage>19</epage><pages>19-19</pages><artnum>19</artnum><issn>2054-9369</issn><issn>2095-7467</issn><eissn>2054-9369</eissn><abstract>Drug delivery systems (DDS) have recently emerged as a promising approach for the unique advantages of drug protection and targeted delivery. However, the access of nanoparticles/drugs to the central nervous system (CNS) remains a challenge mainly due to the obstruction from brain barriers. Immune cells infiltrating the CNS in the pathological state have inspired the development of strategies for CNS foundation drug delivery. Herein, we outline the three major brain barriers in the CNS and the mechanisms by which immune cells migrate across the blood-brain barrier. We subsequently review biomimetic strategies utilizing immune cell-based nanoparticles for the delivery of nanoparticles/drugs to the CNS, as well as recent progress in rationally engineering immune cell-based DDS for CNS diseases. Finally, we discuss the challenges and opportunities of immune cell-based DDS in CNS diseases to promote their clinical development.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>38549161</pmid><doi>10.1186/s40779-024-00521-y</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7697-0378</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2054-9369
ispartof Military medical research, 2024-03, Vol.11 (1), p.19-19, Article 19
issn 2054-9369
2095-7467
2054-9369
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e4dd5b88d2174408981517c661dabc94
source Publicly Available Content Database; PubMed Central
subjects Antigens
Blood vessels
Blood-Brain Barrier
Brain
Cell adhesion & migration
Central nervous system
Central Nervous System Diseases - drug therapy
Chemokines
Drug Delivery Systems
Drugs
Epilepsy
Fatty acids
Glycoproteins
Homeostasis
Humans
Immune cells
Leukocytes
Ligands
Medical research
Multiple sclerosis
Nanoparticles
Nanoparticles - therapeutic use
Nervous system
Physiology
Spinal cord
title Immune cells: potential carriers or agents for drug delivery to the central nervous system
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A42%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20cells:%20potential%20carriers%20or%20agents%20for%20drug%20delivery%20to%20the%20central%20nervous%20system&rft.jtitle=Military%20medical%20research&rft.au=Zhang,%20Shan-Shan&rft.date=2024-03-29&rft.volume=11&rft.issue=1&rft.spage=19&rft.epage=19&rft.pages=19-19&rft.artnum=19&rft.issn=2054-9369&rft.eissn=2054-9369&rft_id=info:doi/10.1186/s40779-024-00521-y&rft_dat=%3Cproquest_doaj_%3E3037875236%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-453665047a503e871afb6b23b8b288f70e8feba21abb5f3e754e3e8a9f7751873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3037875236&rft_id=info:pmid/38549161&rfr_iscdi=true